
In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
Among respondents to RN Magazine's latest nurses' poll, nearly three-quarters (73%) reported that the recession has had a direct impact on their salary.






